Patrick Soon-Shiong steps down as CEO of NantKwest, a linchpin of his 'Cancer Moonshot'

Five years after he took public what was then the most valuable IPO in biotech history, billionaire surgeon Patrick Soon-Shiong is stepping down as CEO of NantKwest.